Search results
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 1 day agoIn one study, Pfizer's Seagen-acquired drug, Adcetris, reduced the risk of death by 37% for patients...
Ultragenyx seeks $350M, rare accelerated approval for rare disease gene therapy - San Francisco...
The Business Journals· 7 hours agoUltragenyx Pharmaceutical Inc. hopes to sell up to $350 million in stock and pre-funded warrants as...
'General Hospital' star Johnny Wactor's unsolved murder is latest tragedy in soap opera's dark...
Fox News via Yahoo News· 4 days agoJohnny Wactor is the latest "General Hospital" alum to reach a tragic fate. Wactor was shot in Los...
Madrigal Pharmaceuticals (NASDAQ:MDGL) Now Covered by Wolfe Research
ETF DAILY NEWS· 3 days agoWolfe Research initiated coverage on shares of Madrigal Pharmaceuticals (NASDAQ:MDGL – Get Free Report) in a report released on Tuesday, Briefing.com reports. The firm set ...
Milestone Pharmaceuticals to Host KOL Event for Investors “Learnings from the Field: Expert...
Digital Journal· 2 days agoMany health care providers are dissatisfied with the lack of effective treatment options with patients often requiring prolonged, burdensome, and costly trips to the emergency department or ...
Weight loss jabs not a quick fix to get beach-body ready, warns top NHS doc
Daily Express· 10 hours agoPowerful weight loss jabs are not “a quick fix for people trying to get ‘beach body ready’” this...
Supreme Court Upholds Access to Abortion Pill
Verywell Health via Yahoo News· 8 hours agoThey said that less than 0.32% of patients experience adverse events related to the drug and that the risk of death “is almost non-existent.” “Few drugs...
Why Blue Cross of Michigan is axing coverage of popular weight loss drugs
Detroit News· 2 days agoBlue Cross Blue Shield of Michigan is dropping coverage of popular weight loss drugs, citing...
Johnson & Johnson talc settlement lands Delaware nearly $5 million
Delaware Online | The News Journal via Yahoo News· 12 hours agoDelaware will receive nearly $5 million from Johnson & Johnson as part of a $700 million national settlement over claims that the pharmaceutical company misled customers regarding ...
Akira Endo, researcher who found cholesterol-fighting statins, dies at 90
Washington Post· 2 days agoThe death was announced by Tokyo University of Agriculture and Technology, where Dr. Endo was a...